Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/179325
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJuárez-Jiménez, Jordi-
dc.contributor.authorGupta, Arun A.-
dc.contributor.authorKarunanithy, Gogulan-
dc.contributor.authorMey, Antonia S. J. S.-
dc.contributor.authorGeorgiou, Charis-
dc.contributor.authorIoannidis, Harris-
dc.contributor.authorDe Simone, Alessio-
dc.contributor.authorBarlow, Paul N.-
dc.contributor.authorHulme, Alison N.-
dc.contributor.authorWalkinshaw, Malcolm D.-
dc.contributor.authorBaldwin, Andrew J.-
dc.contributor.authorMichel, Julien-
dc.date.accessioned2021-07-22T11:00:40Z-
dc.date.available2021-07-22T11:00:40Z-
dc.date.issued2020-01-15-
dc.identifier.issn2041-6520-
dc.identifier.urihttp://hdl.handle.net/2445/179325-
dc.description.abstractProteins need to interconvert between many conformations in order to function, many of which are formed transiently, and sparsely populated. Particularly when the lifetimes of these states approach the millisecond timescale, identifying the relevant structures and the mechanism by which they interconvert remains a tremendous challenge. Here we introduce a novel combination of accelerated MD (aMD) simulations and Markov state modelling (MSM) to explore these 'excited' conformational states. Applying this to the highly dynamic protein CypA, a protein involved in immune response and associated with HIV infection, we identify five principally populated conformational states and the atomistic mechanism by which they interconvert. A rational design strategy predicted that the mutant D66A should stabilise the minor conformations and substantially alter the dynamics, whereas the similar mutant H70A should leave the landscape broadly unchanged. These predictions are confirmed using CPMG and R1ρ solution state NMR measurements. By efficiently exploring functionally relevant, but sparsely populated conformations with millisecond lifetimes in silico, our aMD/MSM method has tremendous promise for the design of dynamic protein free energy landscapes for both protein engineering and drug discovery.-
dc.format.extent20 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherRoyal Society of Chemistry-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1039/C9SC04696H-
dc.relation.ispartofChemical Science, 2020, vol. 11, p. 2670-2689-
dc.relation.urihttps://doi.org/10.1039/C9SC04696H-
dc.rightscc-by (c) Juárez-Jiménez et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationProteïnes-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationCompostos heterocíclics-
dc.subject.classificationCompostos orgànics-
dc.subject.otherProteins-
dc.subject.otherDrug design-
dc.subject.otherHeterocyclic compounds-
dc.subject.otherOrganic compounds-
dc.titleDynamic design: manipulation of millisecond timescale motions on the energy landscape of cyclophilin A-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec700947-
dc.date.updated2021-07-22T11:00:40Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/655667/EU//ISOTRAPSS-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/336289/EU//EBDD-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34084326-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
700947.pdf1.21 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons